ClearPoint Neuro, Inc. (CLPT)
USD 11.31
(-6.8%)
USD 11.31
(-6.8%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 42.66 Million USD | -23.12% |
| 2022 | 55.49 Million USD | -15.39% |
| 2021 | 65.58 Million USD | 121.26% |
| 2020 | 29.64 Million USD | 148.52% |
| 2019 | 11.92 Million USD | 51.8% |
| 2018 | 7.85 Million USD | -43.47% |
| 2017 | 13.89 Million USD | 87.78% |
| 2016 | 7.4 Million USD | -26.74% |
| 2015 | 10.1 Million USD | -24.53% |
| 2014 | 13.38 Million USD | 70.02% |
| 2013 | 7.87 Million USD | 41.81% |
| 2012 | 5.55 Million USD | 83.2% |
| 2011 | 3.03 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 52.57 Million USD | -1.98% |
| 2024 Q1 | 53.63 Million USD | 25.73% |
| 2023 Q4 | 42.66 Million USD | -2.68% |
| 2023 Q3 | 43.83 Million USD | -7.98% |
| 2023 FY | 42.66 Million USD | -23.12% |
| 2023 Q2 | 47.64 Million USD | -5.19% |
| 2023 Q1 | 50.24 Million USD | -9.45% |
| 2022 Q3 | 57.73 Million USD | -4.15% |
| 2022 Q4 | 55.49 Million USD | -3.89% |
| 2022 FY | 55.49 Million USD | -15.39% |
| 2022 Q1 | 61.76 Million USD | -5.81% |
| 2022 Q2 | 60.24 Million USD | -2.47% |
| 2021 Q3 | 68.7 Million USD | -5.01% |
| 2021 Q4 | 65.58 Million USD | -4.54% |
| 2021 Q1 | 74.26 Million USD | 150.55% |
| 2021 Q2 | 72.32 Million USD | -2.61% |
| 2021 FY | 65.58 Million USD | 121.26% |
| 2020 Q1 | 23.58 Million USD | 97.76% |
| 2020 Q2 | 23.03 Million USD | -2.34% |
| 2020 Q3 | 21.84 Million USD | -5.15% |
| 2020 Q4 | 29.64 Million USD | 35.67% |
| 2020 FY | 29.64 Million USD | 148.52% |
| 2019 FY | 11.92 Million USD | 51.8% |
| 2019 Q1 | 7.62 Million USD | -2.94% |
| 2019 Q3 | 13.38 Million USD | 0.9% |
| 2019 Q2 | 13.26 Million USD | 74.01% |
| 2019 Q4 | 11.92 Million USD | -10.92% |
| 2018 Q2 | 11.58 Million USD | -6.16% |
| 2018 FY | 7.85 Million USD | -43.47% |
| 2018 Q4 | 7.85 Million USD | -9.46% |
| 2018 Q3 | 8.67 Million USD | -25.11% |
| 2018 Q1 | 12.34 Million USD | -11.15% |
| 2017 Q4 | 13.89 Million USD | -10.11% |
| 2017 Q1 | 6.19 Million USD | -16.35% |
| 2017 Q3 | 15.45 Million USD | -8.26% |
| 2017 Q2 | 16.85 Million USD | 172.21% |
| 2017 FY | 13.89 Million USD | 87.78% |
| 2016 Q2 | 6.44 Million USD | -22.29% |
| 2016 Q4 | 7.4 Million USD | -17.9% |
| 2016 FY | 7.4 Million USD | -26.74% |
| 2016 Q1 | 8.29 Million USD | -17.93% |
| 2016 Q3 | 9.01 Million USD | 39.9% |
| 2015 Q2 | 7.85 Million USD | -26.87% |
| 2015 Q3 | 6.27 Million USD | -20.17% |
| 2015 FY | 10.1 Million USD | -24.53% |
| 2015 Q4 | 10.1 Million USD | 61.05% |
| 2015 Q1 | 10.74 Million USD | -19.73% |
| 2014 FY | 13.38 Million USD | 70.02% |
| 2014 Q1 | 10.04 Million USD | 27.62% |
| 2014 Q2 | 8.47 Million USD | -15.63% |
| 2014 Q3 | 6.5 Million USD | -23.26% |
| 2014 Q4 | 13.38 Million USD | 105.78% |
| 2013 Q3 | 9.52 Million USD | -13.36% |
| 2013 Q2 | 10.98 Million USD | -15.63% |
| 2013 Q1 | 13.02 Million USD | 134.59% |
| 2013 FY | 7.87 Million USD | 41.81% |
| 2013 Q4 | 7.87 Million USD | -17.3% |
| 2012 Q3 | 7.49 Million USD | 55.01% |
| 2012 Q4 | 5.55 Million USD | -25.91% |
| 2012 Q2 | 4.83 Million USD | 18.72% |
| 2012 Q1 | 4.07 Million USD | 34.37% |
| 2012 FY | 5.55 Million USD | 83.2% |
| 2011 FY | 3.03 Million USD | 0.0% |
| 2011 Q4 | 3.03 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -36.01% |
| BrainsWay Ltd. | 62.97 Million USD | 32.254% |
| Cerus Corporation | 197.74 Million USD | 78.427% |
| Envoy Medical, Inc. | 7.64 Million USD | -458.39% |
| electroCore, Inc. | 16.38 Million USD | -160.334% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -454.615% |
| IceCure Medical Ltd | 16.41 Million USD | -159.97% |
| Inogen, Inc. | 326.19 Million USD | 86.922% |
| OrthoPediatrics Corp. | 449.58 Million USD | 90.511% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -56.439% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -157.319% |
| MaxCyte, Inc. | 268.27 Million USD | 84.098% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -426.854% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1074.614% |
| Orthofix Medical Inc. | 925.31 Million USD | 95.39% |
| PAVmed Inc | 33.11 Million USD | -28.811% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 70.261% |
| RxSight, Inc. | 182.55 Million USD | 76.631% |
| Sight Sciences, Inc. | 166.65 Million USD | 74.401% |
| SI-BONE, Inc. | 230.42 Million USD | 81.486% |
| TELA Bio, Inc. | 78.04 Million USD | 45.34% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 83.065% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -297.586% |
| Acutus Medical, Inc. | 53.96 Million USD | 20.94% |
| Talis Biomedical Corporation | 98.34 Million USD | 56.619% |
| Spectral AI, Inc. | 10.69 Million USD | -298.999% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 80.489% |
| CVRx, Inc. | 115.22 Million USD | 62.977% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 27.275% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1269.423% |
| Bioventus Inc. | 810.91 Million USD | 94.739% |
| Venus Concept Inc. | 93.65 Million USD | 54.448% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -65.835% |
| LivaNova PLC | 2.42 Billion USD | 98.244% |
| 908 Devices Inc. | 202.98 Million USD | 78.983% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 94.702% |
| Nemaura Medical Inc. | 14.56 Million USD | -192.936% |
| NeuroPace, Inc. | 107.65 Million USD | 60.371% |
| LENSAR, Inc. | 69.58 Million USD | 38.692% |
| Apyx Medical Corporation | 79.24 Million USD | 46.162% |
| Cutera, Inc. | 346.29 Million USD | 87.681% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -1.535% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2272.692% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 84.237% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.872% |
| Axonics, Inc. | 719.92 Million USD | 94.074% |
| Outset Medical, Inc. | 313.8 Million USD | 86.405% |
| IRIDEX Corporation | 34.43 Million USD | -23.885% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 89.459% |
| IRadimed Corporation | 92.15 Million USD | 53.708% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -711.972% |
| INVO Bioscience, Inc. | 20.88 Million USD | -104.239% |
| Telesis Bio, Inc. | 70.41 Million USD | 39.411% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 72.316% |
| Varex Imaging Corporation | 1.24 Billion USD | 96.586% |
| Quipt Home Medical Corp. | 247.4 Million USD | 82.757% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -358.228% |
| Pulmonx Corporation | 178.95 Million USD | 76.161% |
| Dynatronics Corporation | 25.94 Million USD | -64.457% |
| Modular Medical, Inc. | 13.8 Million USD | -208.981% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -297.697% |
| Semler Scientific, Inc. | 78.06 Million USD | 45.352% |
| InMode Ltd. | 863.28 Million USD | 95.058% |
| Bruker Corporation | 4.24 Billion USD | 98.996% |
| Cytosorbents Corporation | 53.26 Million USD | 19.901% |
| DexCom, Inc. | 6.26 Billion USD | 99.319% |
| Align Technology, Inc. | 6.08 Billion USD | 99.299% |
| Viveve Medical, Inc. | 25.91 Million USD | -64.632% |
| ZimVie Inc. | 1.2 Billion USD | 96.461% |
| Movano Inc. | 9.42 Million USD | -352.829% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 91.428% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1074.614% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 27.275% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 95.522% |
| Profound Medical Corp. | 43.68 Million USD | 2.347% |
| Insulet Corporation | 2.58 Billion USD | 98.352% |
| enVVeno Medical Corporation | 48.63 Million USD | 12.283% |
| Surmodics, Inc. | 185.73 Million USD | 77.031% |
| iCAD, Inc. | 41.41 Million USD | -3.001% |
| Nuwellis, Inc. | 9.77 Million USD | -336.653% |
| Biotricity, Inc. | 5.94 Million USD | -617.881% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 90.151% |
| Aethlon Medical, Inc. | 8.24 Million USD | -417.355% |
| InspireMD, Inc. | 47.64 Million USD | 10.457% |
| PAVmed Inc. | 33.11 Million USD | -28.811% |
| BIOLASE, Inc. | 35.1 Million USD | -21.538% |
| Beyond Air, Inc. | 56.96 Million USD | 25.105% |
| FONAR Corporation | 214.24 Million USD | 80.088% |
| AxoGen, Inc. | 196.82 Million USD | 78.326% |
| Vivani Medical, Inc. | 45.79 Million USD | 6.848% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 84.842% |
| Inari Medical, Inc. | 674.23 Million USD | 93.673% |
| UFP Technologies, Inc. | 404.13 Million USD | 89.444% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -82.323% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -348.916% |
| Tenon Medical, Inc. | 6.34 Million USD | -572.356% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -353.503% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 58.84% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.077% |
| Sintx Technologies, Inc. | 15.36 Million USD | -177.651% |
| NanoVibronix, Inc. | 6.67 Million USD | -539.212% |
| Quanterix Corporation | 425.01 Million USD | 89.962% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -358.228% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 20.597% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.557% |
| TransMedics Group, Inc. | 706.04 Million USD | 93.958% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 32.49% |
| NeuroMetrix, Inc. | 21.42 Million USD | -99.123% |
| Hyperfine, Inc. | 94.19 Million USD | 54.712% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 84.12% |
| Biomerica, Inc. | 9.25 Million USD | -361.001% |
| Bone Biologics Corporation | 3.73 Million USD | -1041.351% |
| AVITA Medical, Inc. | 144.33 Million USD | 70.444% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -776.26% |
| Silk Road Medical, Inc | 265.3 Million USD | 83.92% |